Evidence map›Paper›PMID 29186874›Full record

ArticleInternational journal of environmental research and public health2017

Do Cervical Cancer Patients Diagnosed with Opportunistic Screening Live Longer? An Arkhangelsk Cancer Registry Study.

Elena E Roik, Evert Nieboer, Olga A Kharkova, Andrej M Grjibovski, Vitaly A Postoev, Jon Ø Odland

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elena E RoikDepartment of Community Medicine, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø N-9037, Norway. roik.elena@gmail.com.
Evert NieboerDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, L8S 4L4, Canada. nieboere@mcmaster.ca.
Olga A KharkovaDepartment of Community Medicine, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø N-9037, Norway. olga.a.kharkova@uit.no.
Andrej M GrjibovskiInternational School of Public Health, Northern State Medical University, Arkhangelsk 163000, Russia. andrej.grjibovski@gmail.com.
Vitaly A PostoevInternational School of Public Health, Northern State Medical University, Arkhangelsk 163000, Russia. vipostoev@yandex.ru.ORCID 0000-0003-4982-4169
Jon Ø OdlandDepartment of Community Medicine, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø N-9037, Norway. jon.oyvind.odland@uit.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the current study was to compare cervical cancer (СС) patients diagnosed with and without screening in terms of: (i) sociodemographic and clinical characteristics; (ii) factors associated with survival; and (iii), and levels of risk. A registry-based study was conducted using data from the Arkhangelsk Cancer Registry. It included women with newly diagnosed malignant neoplasm of the uterine cervix during the period of 1 January 2005 to 11 November 2016 (N = 1548). The Kaplan-Meier method, the log-rank test, and Cox regression were applied. Most participants who were diagnosed by screening were at stage I and died less frequently from CC than those diagnosed without screening. The latter group was also diagnosed with СС at a younger age and died younger. Younger individuals and urban residents diagnosed with stage I and II, squamous cell carcinoma had longer survival times. Cox regression modeling indicated that the hazard ratio for death among women with CC diagnosed without screening was 1.61 (unadjusted) and 1.37 (adjusted). CC diagnosed by screening, cancer stage, patient residence, histological tumor type, and age at diagnosis were independent prognostic variables of longer survival time with CC. Diagnosis of CC made within a screening program improved survival.

Indexed as

Mass ScreeningPrognosisAdultAgedCarcinoma, Squamous CellFemaleHumansLongevityMiddle AgedNeoplasm StagingProportional Hazards ModelsRegistriesRisk FactorsUterine Cervical NeoplasmsArkhangelsk Cancer Registrycervical cancerRussiascreeningsurvivaluterine

Identifiers

PMID29186874
PMCPMC5750918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.